AB
IDYA icon

Amalgamated Bank’s IDEAYA Biosciences IDYA Stock Holding History

Amalgamated Bank’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,523
Closed -$87K – 2189
2025
Q4 		$87K Sell
2,523
-79
-3% -$2.52K ﹤0.01% 1719
2025
Q3 		$71K Sell
2,602
-323
-11% -$7.81K ﹤0.01% 1753
2025
Q2 		$61K Hold
2,925
– – ﹤0.01% 1786
2025
Q1 		$48K Buy
2,925
+85
+3% +$1.81K ﹤0.01% 1801
2024
Q4 		$73K Hold
2,840
– – ﹤0.01% 1759
2024
Q3 		$90K Buy
2,840
+530
+23% +$20.1K ﹤0.01% 1725
2024
Q2 		$81K Buy
2,310
+89
+4% +$3.52K ﹤0.01% 1762
2024
Q1 		$97K Sell
2,221
-5,073
-70% -$218K ﹤0.01% 1730
2023
Q4 		$260K Buy
7,294
+89
+1% +$2.66K ﹤0.01% 1715
2023
Q3 		$194K Buy
7,205
+433
+6% +$11K ﹤0.01% 1793
2023
Q2 		$159K Buy
6,772
+2,110
+45% +$43.4K ﹤0.01% 1909
2023
Q1 		$64K Sell
4,662
-1,161
-20% -$19.3K ﹤0.01% 2207
2022
Q4 		$106K Buy
5,823
+1,305
+29% +$22K ﹤0.01% 2104
2022
Q3 		$67K Hold
4,518
– – ﹤0.01% 2332
2022
Q2 		$62K Buy
4,518
+240
+6% +$2.67K ﹤0.01% 2373
2022
Q1 		$48K Buy
+4,278
New +$63.1K ﹤0.01% 2505

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Amalgamated Bank's IDYA Position: Q1 2026 in Review

Amalgamated Bank sold out of IDEAYA Biosciences (IDYA) in Q1 2026, closing a stake of 2,523 shares — an estimated $87K sold.

Amalgamated Bank first reported a position in IDYA in Q1 2022 and held it in 16 quarters. The position peaked at $260K in Q4 2023. 253 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

  • Amalgamated Bank reported no remaining IDEAYA Biosciences position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 2,523 IDEAYA Biosciences shares in Q1 2026, an estimated $87K.
  • Amalgamated Bank first reported a position in IDEAYA Biosciences in Q1 2022 and held it in 16 quarters.
  • Amalgamated Bank's IDEAYA Biosciences position peaked at $260K in Q4 2023.
  • 253 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.